UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
SCHEDULE 13G
|
||
Under the Securities Exchange Act of 1934
|
||
(Amendment No. __)*
|
TScan Therapeutics, Inc.
|
||
(Name of Issuer)
|
Voting Common Stock
|
||
(Title of Class of Securities)
|
89854M101
|
||
(CUSIP Number)
|
April 19, 2024
|
||
(Date of Event which Requires Filing of this Statement)
|
1
|
Names of Reporting Persons.
Cormorant Global Healthcare Master Fund, LP
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
(a) [ ]
|
|
(b) [x]
|
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization.
Cayman Islands
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
6 Shared Voting Power
2,500,000 shares
Refer to Item 4 below.
|
|
7 Sole Dispositive Power
0 shares
|
|
8 Shared Dispositive Power
2,500,000 shares
Refer to Item 4 below.
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,500,000 shares
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
5.15%
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
PN (Partnership)
|
1
|
Names of Reporting Persons.
Cormorant Global Healthcare GP, LLC
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
(a) [ ]
|
|
(b) [x]
|
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization.
Delaware
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
6 Shared Voting Power
2,500,000 shares
Refer to Item 4 below.
|
|
7 Sole Dispositive Power
0 shares
|
|
8 Shared Dispositive Power
2,500,000 shares
Refer to Item 4 below.
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,500,000 shares
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
5.15%
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
OO (Limited Liability Company)
|
1
|
Names of Reporting Persons.
Cormorant Asset Management, LP
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
(a) [ ]
|
|
(b) [x]
|
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization.
Delaware
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
6 Shared Voting Power
2,500,000 shares
Refer to Item 4 below.
|
|
7 Sole Dispositive Power
0 shares
|
|
8 Shared Dispositive Power
2,500,000 shares
Refer to Item 4 below.
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,500,000 shares
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
5.15%
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
PN (Partnership)
|
1
|
Names of Reporting Persons.
Bihua Chen
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
(a) [ ]
|
|
(b) [x]
|
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization.
United States
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
6 Shared Voting Power
2,500,000 shares
Refer to Item 4 below.
|
|
7 Sole Dispositive Power
0 shares
|
|
8 Shared Dispositive Power
2,500,000 shares
Refer to Item 4 below.
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,500,000 shares
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
5.15%
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
IN (Individual)
|
(a)
|
Name of Issuer
|
TScan Therapeutics, Inc.
|
|
(b)
|
Address of Issuer’s Principal Executive Offices
|
830 Winter Street, Waltham, Massachusetts 02451
|
(a)
|
Name of Person Filing
|
Cormorant Global Healthcare Master Fund, LP Cormorant Global Healthcare GP, LLC Cormorant Asset Management, LP
Bihua Chen |
|
(b)
|
Address of Principal Business Office or, if none, Residence
|
200 Clarendon Street, 52nd Floor
Boston, MA 02116
|
|
(c)
|
Citizenship
|
Cormorant Global Healthcare Master Fund, LP - Cayman Islands
Cormorant Global Healthcare GP, LLC - Delaware Cormorant Asset Management, LP - Delaware
Bihua Chen - United States |
|
(d)
|
Title of Class of Securities
|
Voting Common Stock
|
|
(e)
|
CUSIP Number
|
89854M101
|
Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
(a)
|
[ ]
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
(b)
|
[ ]
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
(c)
|
[ ]
|
Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
|
(d)
|
[ ]
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
(e)
|
[ ]
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
(f)
|
[ ]
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
(g)
|
[ ]
|
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
(h)
|
[ ]
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
(i)
|
[ ]
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
(j)
|
[ ]
|
A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
|
(k)
|
[ ]
|
Group, in accordance with §240.13d-1(b)(1)(ii)(K).
|
Item 4. |
Ownership***
|
Item 5. |
Ownership of Five Percent or Less of a Class
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
|
Item 8. |
Identification and Classification of Members of the Group
|
Item 9. |
Notice of Dissolution of Group
|
Item 10. |
Certification
|
|
CORMORANT GLOBAL HEALTHCARE MASTER
|
|
|
FUND, LP
|
|
|
By:
|
Cormorant Global Healthcare GP, LLC
|
|
|
its General Partner
|
|
|
|
|
By:
|
/s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
|
|
|
|
CORMORANT GLOBAL HEALTHCARE GP, LLC
|
|
|
|
|
|
By:
|
/s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
|
|
|
|
CORMORANT ASSET MANAGEMENT, LP
|
|
|
By:
|
Cormorant Asset Management GP, LLC
|
|
|
its General Partner
|
|
|
|
|
By:
|
/s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
|
|
|
|
/s/ Bihua Chen
|
|
|
Bihua Chen
|
|
CORMORANT GLOBAL HEALTHCARE MASTER
|
|
|
FUND, LP
|
|
|
By:
|
Cormorant Global Healthcare GP, LLC
|
|
|
its General Partner
|
|
|
|
|
By:
|
/s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
|
|
|
|
CORMORANT GLOBAL HEALTHCARE GP, LLC
|
|
|
|
|
|
By:
|
/s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
|
|
|
|
CORMORANT ASSET MANAGEMENT, LP
|
|
|
By:
|
Cormorant Asset Management GP, LLC
|
|
|
its General Partner
|
|
|
|
|
By:
|
/s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
|
|
|
|
/s/ Bihua Chen
|
|
|
Bihua Chen
|